Rafael Amado - Insider Trading & Ownership

Location
210 East Grand Ave, South San Francisco, CA
Summary
The estimated net worth of Rafael Amado is at least $7.13M dollars as of August 12, 2025. Rafael Amado is the EVP of R&D of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $5.27M. Rafael Amado is the President, Head of Global Oncology Research and Development of Zai Lab Ltd and owns shares of Zai Lab Ltd (ZLAB) stock worth about $1.86M.
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Rafael Amado

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALLO Allogene Therapeutics, Inc. EVP of R&D $5.27M Oct 7, 2022
ZLAB Zai Lab Ltd President, Head of Global Oncology Research and Development $1.86M -$790K -29.8% Aug 8, 2025
PSTX Poseida Therapeutics, Inc. Director $0 Jan 8, 2025

Insider Transactions Reported by Rafael Amado:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.